Literature DB >> 19190206

Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

Pouran Layegh1, Fakhrozaman Pezeshkpoor, Amir Hossein Soruri, Parisa Naviafar, Toktam Moghiman.   

Abstract

We compared intralesional glucantine and cryotherapy for treatment of children with cutaneous leishmaniasis in Iran. We observed that cryotherapy is an effective treatment for cutaneous leishmaniasis in children. No serious post-treatment side effects were observed in either group. At six months of follow-up, no recurrence of disease was observed in cured patients in either group. Because of its simplicity, lower cost, low rate of serious complications, and greater tolerability, cryotherapy should be recommended as an appropriate alternative treatment for leishmaniasis in children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190206

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

Review 3.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

4.  A Clinicoepidemiological Study of Pediatric Cutaneous Leishmaniasis in Sinjar Province, Iraq.

Authors:  Nawfal R Hussein
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

5.  Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.

Authors:  Pouran Layegh; Sara Rahsepar; Amir Ali Rahsepar
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

6.  The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.

Authors:  Azar Shokri; Iraj Sharifi; Ali Khamesipour; Nozar Nakhaee; Majid Fasihi Harandi; Jafar Nosratabadi; Maryam Hakimi Parizi; Mohammad Barati
Journal:  Parasitol Res       Date:  2011-08-17       Impact factor: 2.289

Review 7.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

8.  Successful treatment of canine cutaneous leishmaniasis using radio-frequency induced heat (RFH) therapy.

Authors:  Anil A Ahuja; Ram A Bumb; Rajesh D Mehta; Neha Prasad; Ram K Tanwar; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

9.  Manifestations of paediatric Leishmania infantum infections in Malta.

Authors:  David Pace; Thomas N Williams; Alicja Grochowska; Alexandra Betts; Simon Attard-Montalto; Michael J Boffa; Cecil Vella
Journal:  Travel Med Infect Dis       Date:  2011-01-05       Impact factor: 6.211

10.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.